# Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

> clinical trial · VERIFIED · 2026-08-24

Status: RECRUITING · Sponsor: RenovoRx · Condition: Locally Advanced Pancreatic Cancer

- Company: RenovoRx
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03257033

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.